Concepedia

Author

Adele K. Fielding

University College LondonORCID

Also Known As

A Fielding, A K Fielding, A. FIELDING, A. Fielding, A. K. Fielding, A.K Fielding, A.K. Fielding, ADELE K. FIELDING, Adele Fielding, Adele K Fielding

292

Publications

15.5K

Citations

58

H-Index

82

Concepts

All Affiliations

University College LondonNewcastle UniversityCRUK Lung Cancer Centre of ExcellenceThe Royal Free HospitalUniversity Hospitals Bristol NHS Foundation Trust
AK

About

Adele K. Fielding is an author at University College London specializing in medicine, hematology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

21

25

3.4K

2

Health Sciences

9

9

1.2K

3

Engineering

1

1

68

4

Natural Sciences

1

1

74

5

Public Health

1

1

97

Adele K. Fielding

×

99

Publications

14K

Citations

55

H-Index

YearCitations

Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia

Hagop Kantarjian, Anthony S. Stein, Nicola Gökbuget,

New England Journal of Medicine

2017

2K

Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study

Max S. Topp, Nicola Gökbuget, Anthony S. Stein,

The Lancet Oncology

2014

1.2K

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study

Adele K. Fielding, Susan Richards, Rajesh Chopra,

Blood

2006

827

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)

Anthony H. Goldstone, Susan Richards, Hillard M. Lazarus,

Blood

2007

780

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial

Anthony V. Moorman, Christine J. Harrison, Georgina Buck,

Blood

2006

728

Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome–Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study

Giovanni Martinelli, Nicolas Boissel, Patrice Chevallier,

Journal of Clinical Oncology

2017

437

Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

D. Hoelzer, Renato Bassan, Hervé Dombret,

Annals of Oncology

2016

435

T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993)

David I. Marks, Elisabeth Paietta, Anthony V. Moorman,

Blood

2009

409

Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers

Richard S. Maser, Bhudipa Choudhury, Peter J. Campbell,

Nature

2007

374

UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia

Adele K. Fielding, Jacob M. Rowe, Georgina Buck,

Blood

2013

365

Page 1